Healthy Skepticism Library item: 5734
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: news
Strategies for Navigating New Pharma State Gift Laws
FDAnews 2006 Jul 28
http://www.fdanews.com/wbi/conferences/stategiftlaws.html?s=12248&p=067KML
Notes:
Ralph Faggotter’s Comments:
“ Pharmaceutical executives face a nightmare scenario, with an avalanche of strict state regulations on gifting to physicians on the horizon.”
Here’s a simple bit of advice to pharmaceutical executives: Save yourselves a lot of time , money and headaches by not giving doctors presents at all. Not only will this same time and money, and stress, but it will also enhance the self-respect (and the mutual respect) of both the doctors and the pharmaceutical executives.
The doctors will be able to appraise the products more objectively and the general public will benefit in a win-win-win situation.
Full text:
Strategies for Navigating New Pharma State Gift Laws
An audioconference
Wednesday, Aug. 9, 2006 • 1:30 p.m. – 3:00 p.m. EDT
Pharmaceutical executives face a nightmare scenario, with an avalanche of strict state regulations on gifting to physicians on the horizon. The reality is that states are rushing to pass legislation, and you could be faced with 50 new, different compliance reporting systems. Besides expensive fines and state investigations, you could find yourself buried under mountains of paperwork needed to comply – if you don’t prepare now.
In this 90-minute audioconference, Keith Korenchuk, partner with McGuireWoods, Ron Buzzeo, chief regulatory officer, Dendrite International, and Paul Silver, managing director, Huron Consulting Group, team up to give you strategies to navigate this new regulatory minefield.
Sign up your entire team to listen in and discover:
* The potential penalties for violations of existing and proposed state gift laws * Six best practices for IT systems development to meet state compliance requirements * Technology considerations you must confront before you develop IT systems * 10 monitoring and auditing techniques you should implement to guide compliance * Tips on software and solutions acquisition that provide flexibility in responses to emerging state requirementsPlus, you get a chance to ask the speakers questions during the Q&A session. Register today to prevent bigger headaches, more monetary penalties and increased complications from regulatory red tape. Get the strategies you need to prepare now.
Meet Your Instructors
Keith Korenchuk, a partner with McGuireWoods, provides leadership and guidance on compliance strategies for pharmaceutical, life science, device and healthcare organizations. He served as CEO of organizations focusing on pharmaceutical and healthcare sector compliance, and co-chaired the health law department of a Top-100 American law firm. Keith is included among The Best Lawyers in America® and holds an MPH from Harvard and a JD from the University of Virginia.
Ron Buzzeo, chief regulatory officer, Dendrite International. Ron advises drug manufacturers, distributors, chain and supermarket pharmacies, clinic pharmacies, hospitals, HMOs, provider pharmacies to long-term care facilities and practitioners. He specializes in counseling firms in compliance issues related to the Prescription Drug Marketing Act. Ron graduated from St. John’s University, College of Pharmacy.
Paul Silver, managing director, Huron Consulting Group. Paul is a global market leader for Huron’s Pharmaceutical and Life Sciences Practice. He has eighteen years of experience in the pharmaceutical, healthcare, and consumer products industry, specializing in compliance and regulatory matters. Paul has provided expert testimony on behalf of pharmaceutical companies in litigation matters involving sales and marketing practices. Paul graduated from the University of Alabama and is a regular speaker at such events as the Pharmaceutical Marketing Compliance Congress, Pharmaceutical and Regulatory Compliance Congress, Corporate Legal Times General Counsel Conference and the Pharmaceutical Compliance Forum.
Register now!
Who Will Benefit
This audioconference is a must for positions in drug, biotech and biologic including:
